DEA schedule
Is Mydayis a controlled substance?
Mydayis contains dextroamphetamine and amphetamine. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Mydayis (dextroamphetamine and amphetamine) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted Mydayis?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 4 prescription listings from 1 labelers, all Schedule II |
| DEA controlled substances list | Amphetamine: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Isomer or salt of the listed substance (21 CFR 1308) |
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Listed by name |
Mydayis NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 54092-477 | MYDAYIS | capsule, extended release | 12.5 mg/1; 12.5 mg/1; 12.5 mg/1; 12.5 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-468 | MYDAYIS | capsule, extended release | 3.125 mg/1; 3.125 mg/1; 3.125 mg/1; 3.125 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-471 | MYDAYIS | capsule, extended release | 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-474 | MYDAYIS | capsule, extended release | 9.375 mg/1; 9.375 mg/1; 9.375 mg/1; 9.375 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
Questions
Is Mydayis a controlled substance?
Yes. Mydayis (dextroamphetamine and amphetamine) is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Is Mydayis a narcotic?
No. The DEA list does not mark dextroamphetamine and amphetamine as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is Mydayis?
Mydayis is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Mydayis
- What is Mydayis used for?FDA label uses
- Generic for MydayisFDA Orange Book
- What is Dextroamphetamine and Amphetamine used for?FDA label uses
- Is Dextroamphetamine and Amphetamine a controlled substance?Schedule II
- Generic for Adderall XRFDA Orange Book
- Generic for AdderallFDA Orange Book
- Central Nervous System Stimulants listFDA drug class
- NDC 54092-468Mydayis NDC record
- NDC 54092-471Mydayis NDC record
- NDC 54092-474Mydayis NDC record
- Schedule II drugs listDEA schedule